These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Effects of a 2,3-oxidosqualene-lanosterol cyclase inhibitor 2,3:22,23-dioxidosqualene and 24,25-epoxycholesterol on the regulation of cholesterol biosynthesis in human hepatoma cell line HepG2. Dollis D, Schuber F. Biochem Pharmacol; 1994 Jul 05; 48(1):49-57. PubMed ID: 8043030 [Abstract] [Full Text] [Related]
6. Inhibition of cholesterol biosynthesis in 3T3 fibroblasts by 2-aza-2,3-dihydrosqualene, a rationally designed 2,3-oxidosqualene cyclase inhibitor. Gerst N, Schuber F, Viola F, Cattel L. Biochem Pharmacol; 1986 Dec 01; 35(23):4243-50. PubMed ID: 3790151 [Abstract] [Full Text] [Related]
12. Effects of a novel 2,3-oxidosqualene cyclase inhibitor on the regulation of cholesterol biosynthesis in HepG2 cells. Mark M, Muller P, Maier R, Eisele B. J Lipid Res; 1996 Jan 31; 37(1):148-58. PubMed ID: 8820110 [Abstract] [Full Text] [Related]
13. RPR 107393, a potent squalene synthase inhibitor and orally effective cholesterol-lowering agent: comparison with inhibitors of HMG-CoA reductase. Amin D, Rutledge RZ, Needle SN, Galczenski HF, Neuenschwander K, Scotese AC, Maguire MP, Bush RC, Hele DJ, Bilder GE, Perrone MH. J Pharmacol Exp Ther; 1997 May 31; 281(2):746-52. PubMed ID: 9152381 [Abstract] [Full Text] [Related]
14. Lord of the rings--the mechanism for oxidosqualene:lanosterol cyclase becomes crystal clear. Huff MW, Telford DE. Trends Pharmacol Sci; 2005 Jul 31; 26(7):335-40. PubMed ID: 15951028 [Abstract] [Full Text] [Related]
16. Quinuclidine inhibitors of 2,3-oxidosqualene cyclase-lanosterol synthase: optimization from lipid profiles. Brown GR, Hollinshead DM, Stokes ES, Clarke DS, Eakin MA, Foubister AJ, Glossop SC, Griffiths D, Johnson MC, McTaggart F, Mirrlees DJ, Smith GJ, Wood R. J Med Chem; 1999 Apr 08; 42(7):1306-11. PubMed ID: 10197973 [Abstract] [Full Text] [Related]
17. Inhibition of cholesterol synthesis by squalene synthase inhibitors does not induce myotoxicity in vitro. Flint OP, Masters BA, Gregg RE, Durham SK. Toxicol Appl Pharmacol; 1997 Jul 08; 145(1):91-8. PubMed ID: 9221828 [Abstract] [Full Text] [Related]
18. Inhibitors of cholesterol biosynthesis. Further studies of the metabolism of 5 alpha-cholest-8(14)-en-3 beta-ol-15-one in rat liver preparations. Monger DJ, Schroepfer GJ. Chem Phys Lipids; 1988 May 08; 47(1):21-46. PubMed ID: 3396133 [Abstract] [Full Text] [Related]